Expert Review of Gastroenterology & Hepatology

Papers
(The H4-Index of Expert Review of Gastroenterology & Hepatology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?201
Managing pain in irritable bowel syndrome: current perspectives and best practice79
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors75
Small bowel transplant – novel indications and recent progress34
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions33
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis32
Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients26
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir25
Elucidating the role of extracellular vesicles in liver injury induced by HIV24
Therapeutic drug monitoring in inflammatory bowel disease: recent developments23
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management21
Targeting liver metabolism: a pathway to cure hepatitis B virus?21
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)21
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?20
A narrative review on the diagnosis and management of constipation in infants20
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences19
Gender-related differences in celiac disease presentation and follow-up in adult patients19
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis19
The assessment of impaired liver function and prognosis in hepatocellular carcinoma19
0.06175708770752